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Background-—Evidence regarding the association of lower extremity peripheral arterial disease with quality of life (QOL) is mainly
from selected clinical populations or relatively small clinical cohorts. Thus, we investigated this association in community-derived
populations.
Methods and Results-—Using data of 5115 participants aged 66 to 90 years from visit 5 (2011-2013) of the Atherosclerosis Risk
in Communities Study, we quantified the associations of ankle-brachial index (ABI) with several QOL parameters, including 12-item
Short-Form Health Survey (SF-12), after accounting for potential confounders using linear and logistic regression models.
Peripheral arterial disease defined by an ABI <0.90 (n=402), was independently associated with a low SF-12 Physical Component
Summary score (3.26 [95% CI 5.60 to 0.92]), compared to the ABI reference 1.10 to 1.19 (n=1900) but not with the Mental
Component Summary score (0.07 [2.21 to 2.06]). A low ABI was significantly associated with poorer status of all SF-12
physical domains (physical functioning, role-physical, bodily pain, and general health) but only vitality out of 4 mental domains.
Similarly, low ABI values were more consistently associated with other physically related QOL parameters (leisure-time exercise/
activity/walking) than mentally related parameters (significant depressive symptoms and hopeless feeling). Lower physical QOL
was observed even in individuals with borderline low ABI (0.90 to 0.99; n=426).
Conclusions-—Low ABI (even borderline) was independently associated with poor QOL, especially for physical components, in
community-dwelling older adults. QOL is a critical element for older adults, and thus, further studies are warranted to assess
whether peripheral arterial disease-specific management can improve QOL in older populations. ( J Am Heart Assoc. 2017;6:
e004519. DOI: 10.1161/JAHA.116.004519.)
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P eripheral arterial disease (PAD), commonly identified byan ankle-brachial index (ABI) less than 0.9, is a growing
problem.1 In the United States, PAD affects over 8 million
individuals,2 with particularly high prevalence among people
aged over 70 years.3,4 Persons with PAD have 3- to 5-fold
higher mortality risk compared with those without PAD.
Increased mortality is mainly driven by a higher cardiovascular
disease (CVD) risk5,6 and reflects the underlying systemic
atherosclerosis process in PAD patients.7
PAD can also impact quality of life (QOL). As the disease
progresses, patients with PAD may develop intermittent
claudication and critical limb ischemia (a condition including
ischemic rest pain, ulcers, or gangrene, with up to 25% risk of
amputation within 1 year of diagnosis),8 leading to the
reduction of health-related QOL. Indeed, several studies have
evaluated the impact of PAD on QOL measures,9-18 but most
of these studies have been conducted in small clinic-based
populations with symptomatic PAD9-14 or in selected popu-
lations with specific cardiovascular disease risk profiles.16,17
The impact of clinical and subclinical PAD on QOL in the
general population is thus yet to be characterized.
The aim of this study was to comprehensively investigate
the association of PAD—across a spectrum of ABI values—
with health-related QOL among older adults in the community
using data from the Atherosclerosis Risk in Communities
(ARIC) Study. We hypothesized that lower ABI value, including
borderline low ABI (ABI <1.00),19 would be comprehensively
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associated with reduced health-related QOL in community-
dwelling older adults. Some people (particularly as they age)
may value QOL relatively more than merely survival, and PAD-
specific management (eg, supervised exercise, pharmacother-
apy, and revascularization) has been shown to improve QOL in
some patients.20,21 Thus, our findings may have clinical and
public health implications.
Methods
Study Population
The ARIC Study is an ongoing prospective cohort originally
designed to investigate the natural history of atherosclerosis
and related cardiovascular events. The cohort consisted of
15 792 participants aged 45 to 64 at baseline visit in 1987-
1989 from 4 US communities: Forsyth County, North
Carolina; Jackson, Mississippi; suburbs of Minneapolis, Min-
nesota; and Washington County, Maryland. The ARIC Study
conducted the fifth examination (visit 5) between June 1,
2011 and August 30, 2013, which 6538 participants aged 66
to 90 years attended. Among these visit attendees, we
excluded 18 nonwhite/nonblack participants, 868 partici-
pants without ABI measurement, and 537 participants with
missing information for QOL data and covariates, leaving the
final population of 5115 participants for this study. A main
reason for missing ABI measurement was home visit provided
to participants who were unable to come to the field centers.
As anticipated from this aspect, 5115 participants in this
study had healthier profiles as compared to those who were
excluded from this analysis (Table S1). All participants gave
informed consent, and the study was approved by the
institutional review board at each study site.
ABI Measurement
ABI was defined as the ratio of systolic blood pressure in the
ankle to the systolic pressure in the arm. An oscillometric
device, OMRON VP-1000 plus (Kyoto, Japan), allowed blood
pressure to be automatically and simultaneously measured in
both ankles and arms by trained and certified technicians
after at least 5 minutes of rest.22 The higher value of the right
or left arm blood pressure was used as the denominator, and
the ABI was calculated for both the right and left legs. The
measurement was repeated after 5 minutes, and the mean
ABI was recorded for each leg. The lower value of right and
left ABI was used for this analysis in general.9,23 One
exception was when both ABIs were greater than 1.0 and at
least 1 ABI was higher than 1.3. In this situation, to capture
pathophysiological information of high ABI (indicating arterial
noncompressibility),2,24-26 we used the higher ABI value for
our analysis.
Health-Related Quality of Life
Our primary measure of health-related QOL relied on the
12-item Short-Form Health Survey (SF-12), which captures
both physical and mental elements of health-related QOL. To
assess the robustness of our findings, we also evaluated
physical activity and hopeless feeling by self-report and
significant depressive symptoms by use of the Epidemiologic
Studies Depression Scale (CES-D) Short Form.
The 12-Item Short-Form Health Survey
The SF-12v2 questionnaire, adopted in the ARIC study, is
designed to assess health-related QOL, which has been
validated across populations27 and is comparable to the
original full form of SF-36.27,28 It reports 2 summary
measurements for physical and mental health-related QOL,
the Physical Component Summary and Mental Component
Summary scores. Each summary component was based on
4 domains: Physical Component Summary—physical func-
tioning (the ability to do moderate activities or climb stairs),
role-physical (impaired working ability or daily activities due
to physical issue), bodily pain (extent to which pain
interferes with daily work), and general health (self-graded
health status); Mental Component Summary—mental health
(whether feeling peaceful or depressed), role-emotional
(impaired working ability or daily activities due to emotional
issue), social functioning (frequency of social activities
interfered by physical or emotional issues), and vitality
(whether feeling energetic). All information was based on
the respondents’ experience during the previous 4 weeks.
The method that defines the calculation of these QOL
scores was published elsewhere.29 Briefly, the answer for
each question was scaled based on the frequency and
intensity of a certain QOL condition using a point between
1 and 5. A higher score indicates better QOL status. A raw
QOL score for each domain was calculated by summing the
points for relevant questions. Then, the final score for each
domain ranging from 0 to 100 was calculated based on the
following formula: ([actual raw scorelowest possible raw
score]/possible raw score range)9100. The QOL scores
used in this study were further standardized to the general
US population in 1998, with a mean of 50 and a
standard deviation of 10. Thus, scores above and below
50 are above and below the average in the general US
population.30
Other Health-Related QOL Variables
Leisure-time exercise frequency, activity level compared to
peers, and walking frequency were collected by questionnaire
during an interview. Participants selected their leisure-time
exercise and walking frequency from 5 categories of “Never,”
“Seldom,” “Sometimes,” “Often,” and “Very Often.” “Never”
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and “Seldom” were defined as “low” for leisure-time exercise
and walking frequency. Similarly, among the 5 categories of
“Much less,” “Less,” “The same,” “More,” and “Much more”
for the question on leisure-time activity compared to their
peers, “Much less” and “Less” were considered “low” leisure-
time activity.
The CES-D Short Form is a measurement instrument of
depression symptoms, with 11 items selected from 20 items
that define the full CES-D Form. This short-form CES-D
demonstrates good validity31 and high correlation with the full
CES-D Form (Pearson r=0.95).32 With a scale between 0 and 2
(0=hardly ever or never; 1=some of the time; 2=much or most
of the time) for each item, the total CES-D score ranges
between 0 and 22. The score was treated as missing if more
than 1 item was missing. Significant depressive symptoms
were defined as any CES-D score ≥9.33 Information about the
frequency of feeling hopeless in the past week (none,
1-2 days, 3-7 days) was gathered via a simple question
asked during the interview. “Hopeless feeling” was defined by
any self-report of feeling hopeless at least 1 day in the
previous week.
Covariates
Age, sex, and race were self-reported. Information regarding
each participant’s education level (high school or lower vs
college or above) was collected during the ARIC visit 1
interview. Subjective economic status was measured based
on the MacArthur scale,34 a self-estimated rank of the family
financial status compared to the whole US population and
ranked into 10 categories (rank score 1 [lowest] to 10
[highest]), and lower economic status was defined as having
a rank score <6 (median score among study participants).
The subjective economic status has demonstrated a good
predictability for health status.35 Smoking and drinking
status were classified as current or not. Body mass index
was calculated as weight (kg) divided by the square of height
(m). Total cholesterol was assessed via enzymatic meth-
ods.36 Glucose level was measured by glucose-6-phosphate
dehydrogenase methods.37 Diabetes mellitus was defined as
fasting glucose level ≥126 mg/dL (≥7 mmol/L), nonfasting
glucose level ≥200 mg/dL (≥11.1 mmol/L), medication use
for diabetes mellitus, or self-reported physician diagnosis.
Hypertension was defined as a systolic blood pressure
(mean of the second and third measurements in sitting
position) ≥140 mm Hg or diastolic blood pressure
≥90 mm Hg or use of antihypertensive medication. History
of coronary heart disease (CHD) or stroke was identified by
the clinical history acquired at visit 1 and study-adjudicated
CHD and stroke events between visit 1 and visit 5,
respectively. History of heart failure was defined as cases
adjudicated by the ARIC physician panel from 2005 onward,
hospitalizations with ICD code 428.x prior to 2005, or heart
failure diagnosis confirmed with the participant’s physician.
Lung disease was based on the self-reported physician
diagnosis of emphysema/chronic obstructive pulmonary
disease, chronic bronchitis, or asthma. Estimated glomerular
filtration rate was derived using the CKD-EPI equation incor-
porating serum creatinine level, sex, race, and age.38
Reduced kidney function was defined as estimated glomeru-
lar filtration rate <60 mL/min per 1.73 m2.38
Statistical Analysis
According to previous literature,19,23,26,39 ABI was a priori
categorized into 6 groups: <0.90, 0.90 to 0.99 (≥0.9 to <1),
1.00 to 1.09 (≥1 to <1.1), 1.10 to 1.19 (≥1.1 to <1.2), 1.20 to
1.29 (≥1.2 to <1.3), and ≥1.30. The category of 1.10 to 1.19
was used as reference because it was the most prevalent
category in our study and was used as a reference in a
previous meta-analysis.23 Participants’ baseline characteris-
tics were compared across these 6 ABI groups based on chi-
squared tests and analysis of variance (ANOVA) tests, as
appropriate. We used linear regression models to evaluate
continuous QOL parameters from the SF-12 (2 summary
components and 8 health-related domains) and logistic
regression models for the other QOL variables (ie, “low”
leisure-time exercise, activity, and walking, significant depres-
sive symptoms, and hopeless feeling). To evaluate the
influence of potential confounders, 3 types of models were
constructed for each QOL parameter. Model 1 adjusted for
demographic variables, age, sex, ethnicity, education level,
and economic status. Model 2 further adjusted for CVD risk
factors (current smoking/drinking status, body mass index,
total cholesterol level, diabetes mellitus, and hypertension)
and history of CVD (history of CHD, heart failure, and stroke).
Model 3 additionally included the presence of noncardio-
vascular comorbidities (lung disease and reduced kidney
function). Because we are particularly interested in the
independent association of ABI with health-related QOL, we
primarily present results derived from Model 3. We repeated
the analysis in subgroups according to sex, race, and the
status of CVD history, diabetes mellitus, and reduced kidney
function. In this subgroup analysis we maintained our analytic
frame of 6 ABI categories for continuous QOL parameters.
However, to obtain reliable estimates, we dichotomized ABI
(<1.00 [low and borderline low]19 and ≥1.00 [as reference])
for dichotomous QOL parameters. Residual normality and
equal variance assumptions were confirmed for the major
outcome variables, the Physical/Mental Component Summary
scores. Due to the ordinal nature of the measurements for
each SF-12 subdomain, the normality assumption did not
necessarily hold for every subdomain. Nonetheless, given the
sample size and the Central Limit Theorem, the comparison of
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average subdomain scores across ABI categories would be
still valid.40 P<0.05 was considered statistically significant.
Results
Participant Characteristics
Themean age of the 5115 participants was 75.4 (SD 5.0) years,
and 21.8% (n=1113) were black. There were 402 participants
(7.9%) with a low ABI <0.90, a category considered as PAD, and
426 (8.3%) with a borderline low ABI of 0.90 to 0.99.41 As
compared to participants with ABI in the reference range (1.10-
1.19), those with lower ABI values (ABI <1.10) tended to have a
worse cardiovascular risk factor profile, namely increased age,
lower socioeconomic status, higher prevalence of current
smoking, diabetes mellitus, hypertension, history of CVD and
chronic lung disease, and reduced kidney function (Table 1).
Those with high ABI (≥1.30) also demonstrated a worse risk
factor profile and more adverse clinical comorbidity profile with
increased age, higher adiposity, higher prevalence of diabetes
mellitus, and prior history of CVD compared to those with ABI in
the reference range (1.10-1.19).
The 12-Item Short-Form Health Survey
In the study population the mean scores for the Physical and
Mental Component Summary were 46.8 (SD 9.9) and 55.5
(SD 7.5), respectively. Compared to the reference of ABI 1.10
to 1.19, individuals with ABI <1.00 demonstrated a signifi-
cantly lower Physical Component Summary score (3.26
[95% CI 5.60 to 0.92] for ABI <0.90 and 2.23 [95% CI
4.07 to 0.39] for ABI 0.90-0.99) in Model 3 (Figure). This
decrement by lower ABI was not significant for the Mental
Component Summary score.
When we looked at each domain separately, ABI <0.90 was
significantly associated with lower scores in all physical
component domains, compared to the reference, in Model 3.
This was most apparent for the physical functioning score
(3.42 [95% CI 5.50 to 1.35]), followed by the role
physical, general health, and bodily pain scores (Table 2 and
Table S2). Individuals with ABI 0.90 to 0.99 had lower scores
for all physical domains compared to the reference group as
well, but the difference reached significance only for the “role-
physical” domain (1.87 [95% CI 3.58 to 0.16]) and bodily
pain domain (1.59 [95% CI 3.13 to 0.05]). As
Table 1. Characteristics of the Study Population According to Categories of ABI, the ARIC Study (2011-2013)
Characteristics
ABI Categories (n)
All (5115) <0.9 (402)
0.90 to 0.99
(426)
1.00 to 1.09
(1234)
1.10 to 1.19
(1900)
1.20 to 1.29
(694) ≥1.3 (459) P Value*
Age (y), mean (SD) 75.4 (5.0) 77.3 (5.5) 76.0 (5.6) 75.3 (5.1) 75.0 (4.8) 74.8 (4.9) 75.5 (4.8) <0.001
Sex (Females) 2948 (57.6%) 214 (53.2%) 298 (70.0%) 878 (71.2%) 1138 (59.9%) 289 (41.6%) 131 (28.5%) <0.001
Blacks 1113 (21.8%) 164 (40.8%) 133 (31.2%) 352 (28.5%) 352 (18.5%) 66 (9.5%) 46 (10.0%) <0.001
Education† 2819 (55.1%) 258 (64.2%) 264 (62.0%) 732 (59.3%) 1029 (54.2%) 339 (48.8%) 197 (42.9%) <0.001
Economic status† 2367 (46.3%) 232 (57.7%) 229 (53.8%) 642 (52.0%) 828 (43.6%) 267 (38.5%) 169 (36.8%) <0.001
Current smoker 297 (5.8%) 56 (13.9%) 53 (12.4%) 77 (6.2%) 80 (4.2%) 16 (2.3%) 15 (3.3%) <0.001
Current drinker 2559 (50.8%) 147 (36.6%) 179 (42.0%) 561 (45.5%) 1040 (54.7%) 410 (59.1%) 262 (57.1%) <0.001
Body mass index
(kg/m2), mean (SD)
28.6 (5.5) 28.9 (5.9) 29.5 (6.6) 29.0 (5.7) 28.2 (5.1) 28.0 (4.7) 29.1 (5.6) <0.001
Total cholesterol
(mmol/L), mean
(SD)
4.7 (1.1) 4.6 (1.1) 4.8 (1.1) 4.8 (1.1) 4.7 (1.1) 4.6 (1.0) 4.4 (1.0) <0.001
Diabetes mellitus 1606 (31.4%) 173 (43.0%) 142 (33.3%) 388 (31.4%) 546 (28.7%) 205 (29.5%) 152 (33.1%) <0.001
Hypertension 3774 (73.8%) 347 (86.3%) 338 (79.3%) 953 (77.2%) 1343 (70.7%) 481 (69.3%) 312 (68.0%) <0.001
CHD history 734 (14.3%) 115 (28.6%) 72 (16.9%) 153 (12.4%) 229 (12.1%) 88 (12.7%) 77 (16.8%) <0.001
Heart failure history 239 (4.7%) 58 (14.4%) 28 (6.6%) 56 (4.5%) 59 (3.1%) 16 (2.3%) 22 (4.8%) <0.001
Stroke history 174 (3.4%) 29 (7.2%) 26 (6.1%) 36 (2.9%) 50 (2.6%) 18 (2.6%) 15 (3.3%) <0.001
Lung disease 566 (11.1%) 72 (17.9%) 64 (15.0%) 155 (12.6%) 185 (9.7%) 54 (7.8%) 36 (7.8%) <0.001
Kidney function† 1424 (27.8%) 176 (43.8%) 160 (37.6%) 351 (28.4%) 463 (24.4%) 156 (22.5%) 118 (25.7%) <0.001
ABI indicates ankle-brachial index; CHD, coronary heart disease.
*P-value calculated by analysis of variance (ANOVA) test for continuous variables and by chi-squared test for categorical variables.
†Showing the prevalence of lower level, ie, lower education level, lower economic status, and reduced kidney function.
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anticipated, a stronger association was observed between
lower ABI values and reduced physical domains in Models 1
and 2 (Tables S3 and S4).
Compared to physical components, the association with
mental domains was weaker (Table 2). One exception was
vitality score, which was significantly lower in ABI categories
<1.00 compared to the reference (1.54 [95% CI 2.25 to
0.83] for ABI <0.9 and 1.38 [95% CI 1.98 to 0.78] for
ABI 0.90-0.99). Similar results were observed in Models 1 and
2 except for the presence of a significant association between
lower ABI and lower role emotional score as well as a more
pronounced ABI-vitality association (Tables S3 and S4). High
ABI ≥1.30 did not demonstrate significantly lower score in any
of the physical and mental domains.
The Other QOL Parameters
We observed dose-response relationships between ABI and
the other physical activity QOL parameters (Table 3). In line
with the results for physical components in SF-12, low ABI
<0.90 was significantly associated with these 3 other physical
activity parameters (OR 1.34 [95% CI 1.09-1.64] for “low”
leisure-time exercise, 1.35 [95% CI 1.21-1.50] for
“low” leisure-time activity, and 1.43 [95% CI 1.25-1.63] for
“low” leisure-time walk) compared to the reference ABI group.
The significantly lower leisure-time activity level and walking
frequency were also observed in borderline low ABI 0.90 to
0.99. Of note, low normal ABI 1.00 to 1.09 was also
significantly associated with these 3 parameters of physical
activity (OR 1.21 [95% CI 1.09-1.35] for “low” leisure-time
exercise, 1.15 [95% CI 1.04-1.26] for “low” leisure-time
activity, and 1.24 [95% CI 1.11-1.39] for “low” leisure-time
walk). Again, stronger associations were observed in Models 1
and 2 (Tables S5 and S6).
The other mental parameters, significant depressive
symptoms and hopeless feeling, demonstrated weaker inde-
pendent associations with lower ABI compared to the other
physical activity parameters (Table 3). Although significant
depressive symptoms tended to associate with lower ABI,
none of the odds ratios was significant. The odds of hopeless
feeling were significantly higher only in borderline low ABI
0.90 to 0.99 compared to the reference ABI group. However,
these mental parameters were consistently associated with
low ABI categories in demographically adjusted Model 1
(Table S5).
Subgroup Analysis
The associations between ABI and physical components of
QOL were also observed in most subgroups tested (Table S7
for SF-12 physical summary score and Table S8 for the other
physical QOL parameters). Notably, the associations between
lower ABI and poor physical QOL components were consis-
tently stronger in participants without a history of CVD than in
those with history of CVD (Tables S7 and S8).
Reflecting overall weak association, we did not observe
consistently lower mental QOL components in any subgroups
for SF-12 mental summary score (Table S9). However, of
interest, for the other mental QOL parameters, lower ABI
(<1.00), compared to ABI ≥1.00, was significantly associated
with higher odds of significant depressive symptoms and
hopeless feeling in whites, whereas lower ABI was signifi-
cantly related to lower odds of those mental conditions in
blacks (Table S10).
Discussion
This study quantified the association between ABI and several
domains of QOL among community-dwelling older adults from
4 US communities. With ABI 1.10 to 1.19 as reference group,
low ABI (<0.90) and borderline low ABI (0.90-0.99) were
associated with poorer QOL status, as defined by a number of
subdomains. The association with lower ABI was more
evident for physical components of QOL than for mental
components in SF-12. The association of ABI with physical
components of QOL was confirmed by analyses of leisure-
time exercise, activity, and walking. A lower ABI was also
significantly associated with a mental domain in SF-12, ie,
vitality, which may be a psychological basis to be engaged in
physical activity. Poor QOL status for physical health
components was observed even among those participants
who were without any other clinically recognized CVD
Figure. The adjusted difference and 95% CI in quality of life (QOL)
scores according to ankle-brachial index (ABI) categories (Physical/
Mental Component Summary from SF-12). Physical Component
Summary and Mental Component Summary scores were adjusted
for age, sex, ethnicity, education level, economic status, current
smoking/drinking status, body mass index, total cholesterol level,
diabetes mellitus, hypertension, history of coronary heart disease,
heart failure, and stroke, lung disease, and reduced kidney function.
DOI: 10.1161/JAHA.116.004519 Journal of the American Heart Association 5
PAD and QOL Among Older Adults Wu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
Ta
bl
e
2.
Fu
lly
Ad
ju
st
ed
*
D
iff
er
en
ce
in
Q
ua
lit
y
of
Li
fe
Sc
or
es
Ac
co
rd
in
g
to
AB
I
C
at
eg
or
ie
s
Q
O
L
D
om
ai
ns
AB
I
C
at
eg
or
ie
s
(n
)
<
0.
90
(4
02
)
0.
90
to
0.
99
(4
26
)
1.
00
to
1.
09
(1
23
4)
1.
10
to
1.
19
(1
90
0)
1.
20
to
1.
29
(6
94
)
≥1
.3
0
(4
59
)
C
oe
ffi
ci
en
t†
(9
5%
C
I)
C
oe
ffi
ci
en
t
(9
5%
C
I)
C
oe
ffi
ci
en
t
(9
5%
C
I)
Re
fe
re
nc
e
C
oe
ffi
ci
en
t
(9
5%
C
I)
C
oe
ffi
ci
en
t
(9
5%
C
I)
Ph
ys
ic
al
co
m
po
ne
nt
s
3
.2
6
(
5.
60
to
0
.9
2)
‡
2
.2
3
(
4.
07
to
0
.3
9)
‡
0
.6
2
(
1.
42
to
0.
19
)
0
0
.5
6
(
1.
71
to
0.
59
)
0
.1
3
(
1.
09
to
0.
82
)
Ph
ys
ic
al
fu
nc
tio
ni
ng
3
.4
2
(
5.
50
to
1
.3
5)
‡
1
.7
1
(
3.
94
to
0.
52
)
0
.6
8
(
1.
58
to
0.
22
)
0
0
.2
1
(
1.
61
to
1.
18
)
0
.4
3
(
1.
58
to
0.
71
)
Ro
le
ph
ys
ic
al
2
.7
6
(
4.
98
to
0
.5
5)
‡
1
.8
7
(
3.
58
to
0
.1
6)
‡
0
.9
0
(
2.
25
to
0.
45
)
0
0
.4
5
(
1.
48
to
0.
58
)
0
.0
1
(
1.
64
to
1.
62
)
Bo
di
ly
pa
in
1
.9
9
(
3.
77
to
0
.2
2)
‡
1
.5
9
(
3.
13
to
0
.0
5)
‡
0
.1
5
(
0.
81
to
0.
52
)
0
1
.0
1
(
2.
48
to
0.
45
)
0
.0
3
(
1.
42
to
1.
35
)
Ge
ne
ra
lh
ea
lth
2
.3
1
(
3.
52
to
1
.0
9)
‡
1
.5
5
(
3.
30
to
0.
20
)
0
.1
6
(
1.
36
to
1.
04
)
0
0.
00
(
1.
16
to
1.
16
)
0.
50
(
0.
63
to
1.
63
)
M
en
ta
lc
om
po
ne
nt
s
0
.0
7
(
2.
21
to
2.
06
)
0.
15
(
0.
96
to
1.
26
)
0.
06
(
0.
54
to
0.
66
)
0
0.
09
(
0.
62
to
0.
79
)
0.
37
(
0.
44
to
1.
19
)
M
en
ta
lh
ea
lth
0
.6
2
(
2.
47
to
1.
23
)
0.
01
(
0.
51
to
0.
53
)
0.
29
(
0.
59
to
1.
17
)
0
0.
04
(
1.
15
to
1.
23
)
0.
47
(
0.
64
to
1.
57
)
Ro
le
em
ot
io
na
l
1
.4
1
(
2.
98
to
0.
16
)
0
.4
2
(
1.
49
to
0.
64
)
0
.7
4
(
1.
49
to
0.
00
)
0
0
.1
3
(
0.
91
to
0.
65
)
0
.1
7
(
0.
97
to
0.
64
)
So
ci
al
fu
nc
tio
ni
ng
0
.5
8
(
2.
07
to
0.
92
)
0
.5
4
(
1.
99
to
0.
92
)
0.
02
(
0.
42
to
0.
46
)
0
0
.0
2
(
1.
23
to
1.
19
)
0.
09
(
1.
27
to
1.
45
)
Vi
ta
lit
y
1
.5
4
(
2.
25
to
0
.8
3)
‡
1
.3
8
(
1.
98
to
0
.7
8)
‡
0
.1
8
(
0.
49
to
0.
13
)
0
0
.3
1
(
0.
88
to
0.
26
)
0.
42
(
0.
03
to
0.
88
)
AB
I
in
di
ca
te
s
an
kl
e-
br
ac
hi
al
in
de
x;
Q
O
L,
qu
al
ity
of
lif
e.
*A
dj
us
te
d
fo
r
ag
e,
se
x,
et
hn
ic
ity
,e
du
ca
tio
n
le
ve
l,
ec
on
om
ic
st
at
us
,c
ur
re
nt
sm
ok
in
g/
dr
in
ki
ng
st
at
us
,b
od
y
m
as
s
in
de
x,
to
ta
lc
ho
le
st
er
ol
,d
ia
be
te
s
m
el
lit
us
,h
yp
er
te
ns
io
n,
hi
st
or
y
of
co
ro
na
ry
he
ar
t
di
se
as
e
(C
H
D
),
he
ar
t
fa
ilu
re
,a
nd
st
ro
ke
,l
un
g
di
se
as
e,
an
d
re
du
ce
d
ki
dn
ey
fu
nc
tio
n.
†
Li
ne
ar
re
gr
es
si
on
co
ef
fi
ci
en
t.
It
re
pr
es
en
ts
th
e
di
ffe
re
nc
e
in
Q
O
L
sc
or
e
be
tw
ee
n
a
gi
ve
n
AB
I
ca
te
go
ry
an
d
th
e
re
fe
re
nc
e
ca
te
go
ry
(1
.1
0-
1.
19
).
‡
In
di
ca
te
s
si
gn
ifi
ca
nt
re
su
lts
.
DOI: 10.1161/JAHA.116.004519 Journal of the American Heart Association 6
PAD and QOL Among Older Adults Wu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
(ie, CHD, stroke, and heart failure) or clinical conditions
tightly related to PAD (eg, reduced kidney function).
The more evident association of low ABI with physical
components of QOL status compared to mental components
of QOL is consistent with previous studies performed in
clinical populations.11,16,17,42 Of note, our study is the first to
test the full spectrum of ABI in this context among commu-
nity-dwelling older adults not selected for clinical conditions.
It is of importance that even borderline low ABI was
associated with reduced physical QOL. There are several
potential mechanisms linking PAD to the impairments for
physical components of QOL. Individuals with low ABI often
have other manifestations of CVD and comorbidities, which
may lead to poor physical condition and reduce QOL.
However, the association of ABI with physical domains of
QOL was independent of major comorbidities. These relation-
ships could certainly be hypothesized to have potential PAD-
specific mechanisms, such as decreased blood flow to the
legs, which can induce clinically significant skeletal muscle
atrophy and denervation through ongoing ischemia.43 Exer-
tional leg pain or discomfort (whether due to classic
claudication or atypical leg pain) may additionally contribute
to these lower physical ability QOL scores. Importantly, fear
of falling was reported among those with intermittent
claudication44 and could further impact and limit their
physical activity.
Low ABI was significantly associated with lower vitality, a
mental measure of QOL. The data from this ARIC analysis are
concordant with those of a previous study that demonstrated
a stronger association of low ABI values with diminished
vitality than with other mental domains.17 We also observed
significant associations with significant depressive symptoms
and hopeless feeling in some low-ABI categories, particularly
in Models 1 and 2. Although the exact mechanisms for the
association between PAD and mental elements of QOL
represented by vitality are not clear, limited physical activity
as well as impaired working ability due to PAD may impact
mental QOL domains. In addition, resting or exertional leg
symptoms or fear of falling due to PAD, mentioned above,
may further contribute to reduced mental elements of QOL.
Although a weaker association was seen among individuals
with a history of CVD than those without, the contribution of
low ABI to physical QOL parameters was qualitatively
consistent across all subgroups tested in our study. The
weaker association among those with a history of CVD may
be due to the fact that many participants with prior CVD had
already reduced QOL, especially for physical components, and
low ABI may not considerably contribute to further discrim-
ination beyond other CVDs. Indeed, the mean Physical
Component Summary score was lower among participants
with a history of CVD compared to those without CVD (43.6
versus 47.5). Regarding mental elements, we observed a
significant qualitative racial interaction for low ABI and
significant depressive symptoms/hopeless feeling, with pos-
itive associations in whites but negative associations in
blacks. The potential background for this interaction is not
Table 3. Fully Adjusted* Odds Ratio of Other Quality of Life Aspects According to ABI Categories
Other QOL Aspects
ABI Categories (n)
<0.90 0.90 to 0.99 (426) 1.00 to 1.09 (1234) 1.10 to 1.19 (1900) 1.20 to 1.29 (694) ≥1.30 (459)
No. Low QOL/Total
OR† (95% CI)
No. Low QOL/Total
OR (95% CI)
No. Low QOL/Total
OR (95% CI) Reference
No. Low QOL/Total
OR (95% CI)
No. Low QOL/Total
OR (95% CI)
Physical activity
“Low” leisure-time
exercise
230/402
1.34 (1.09-1.64)‡
248/426
1.38 (0.98-1.93)
656/1234
1.21 (1.09-1.35)‡
859/1900
1
299/694
1.01 (0.79-1.30)
191/459
0.95 (0.68-1.32)
“Low” leisure-time
activity
101/402
1.35 (1.21-1.50)‡
103/426
1.26 (1.13-1.40)‡
253/1234
1.15 (1.04-1.26)‡
304/1900
1
80/694
0.74 (0.62-0.88)‡
59/459
0.76 (0.60-0.98)‡
“Low” leisure-time
walk
158/402
1.43 (1.25-1.63)‡
162/426
1.38 (1.08-1.76)‡
413/1234
1.24 (1.11-1.39)‡
501/1900
1
163/694
0.94 (0.77-1.14)
110/459
0.93 (0.80-1.08)
Mental health
Significant depressive
symptoms
46/402
1.51 (0.87-2.62)
35/426
1.19 (0.79-1.81)
91/1234
1.22 (0.98-1.52)
95/1900
1
24/694
0.79 (0.46-1.34)
19/459
0.91 (0.62-1.32)
Feel hopeless 55/402
1.13 (0.97-1.31)
56/426
1.20 (1.07-1.33)‡
159/1234
1.32 (0.96-1.80)
165/1900
1
50/694
0.91 (0.63-1.32)
35/459
0.94 (0.53-1.66)
ABI indicates ankle-brachial index; QOL, quality of life.
*Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes mellitus, hypertension, history of
coronary heart disease (CHD), heart failure, and stroke, lung disease, and reduced kidney function.
†Logistic regression models were applied to assess the 5 binary other QOL aspects.
‡Indicates significant results.
DOI: 10.1161/JAHA.116.004519 Journal of the American Heart Association 7
PAD and QOL Among Older Adults Wu et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
clear. Nonetheless, this subgroup analysis should be consid-
ered hypothesis generating, as we tested multiple subgroups
without an a priori hypothesis of biological interaction.
Our findings of the association of low ABI and impaired
QOL among community-dwelling older adults may have some
clinical and public health implications. Staying physically
active is an important goal for older adults as a determinant of
the ability to sustain independent living. Because several
lifestyle (eg, smoking cessation or supervised exercise) or
medical (eg, cilostazol or revascularization) interventions have
demonstrated improvement in physical function among
patients with PAD,45-47 it seems important to identify the
contribution of PAD to the reduction of physical components
of QOL in older adults. It is important to keep in mind that
reduced QOL was also observed in those with borderline low
ABI (<1.00) in our study. Further studies might assess
whether PAD-specific interventions would comprehensively
improve physical components of QOL and vitality in commu-
nity-dwelling older adults with a low ABI but otherwise not
diagnosed as PAD.
Our study has several limitations. First, for any cross-
sectional analysis, it is not possible to establish the tempo-
rality or causality of our observed associations of low ABI with
poor QOL status.48 Second, the ARIC Study did not collect
specific information on leg pain at visit 5. Third, our results
may not be entirely generalizable to racial/ethnic groups
other than whites and blacks. Fourth, it is possible that those
individuals with a very low ABI and/or severely reduced QOL
were less likely to attend ARIC visit 5, raising the possibility
that our results may underestimate the relationship between
low ABI <0.9 and QOL. Finally, as any observational study, we
cannot deny the possibility of residual confounding.
In conclusion, among older adults in the community, those
with ABI <1.0 were independently associated with reduced
QOL status. The association was particularly evident for
physical components of QOL but was also observed for a
mental domain, vitality. Because QOL is a critical element in
addition to survival, especially in older adults, further studies
are warranted to assess the causality of ABI in the develop-
ment of poor QOL and, if so, to explore whether the
management of PAD can improve QOL among older adults
afflicted by this disease.
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Table S1. Baseline characteristics in participants included and those excluded in the analysis 
 
 
 
 
 
 
 
 
 
 
* P-value calculated by analysis of variance (ANOVA) test for continuous variables and by chi-squared test for categorical variables. 
† Using lower level as reference, i.e. lower education level and lower economic status. 
‡ Covariates with missingness but is less than 5% of the total 6520 participants for the study population. 
§ Cardiovascular disease (CVD) history was defined as having any history of coronary heart disease, heart failure or stroke. 
Characteristics Participants Included Participants Excluded 
Number of participants 5115 1405 
Age (year), mean (SD) 75.4 (5.0) 77.5 (5.7) 
Sex(Females) 2948 (57.6%) 887 (63.1%) 
African Americans 1113 (21.8%) 431 (30.7%) 
Education†‡ 2819 (55.1%) 876 (62.8%) 
Economic Status†‡ 2367 (46.3%) 625 (54.6%) 
Body Mass Index‡ (kg/m2), 
Mean (SD) 
28.6 (5.5) 29.5 (7.0) 
Total Cholesterol‡ (mmol/L), 
Mean (SD) 
4.7 (1.1) 4.7 (1.1) 
Diabetes‡ 1606 (31.4%) 515 (45.0%) 
Hypertension‡ 3774 (73.8%) 1040 (79.3%) 
CVD History‡§ 973 (19.0%) 357 (27.5%) 
 3 
Table S2. Description of participant’s SF-12 quality of life (QOL) parameters according to ankle brachial index (ABI) categories 
* P-value calculated by analysis of variance (ANOVA) tests. 
† Mean (SD) was reported.
Characteristics 
ABI categories (n) 
All (5,115) <0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) P-value* 
Physical Component† 46.8 (9.9) 41.9 (10.5) 43.6 (10.8) 46.3 (10.0) 48.1 (9.2) 48.2 (9.5) 48.1 (9.0) <0.001 
Physical Functioning† 47.9 (10.4) 43.0 (11.5) 45.1 (11.6) 47.2 (10.6) 49.0 (9.7) 49.7 (9.7) 49.0 (9.5) <0.001 
Role Physical† 48.5 (9.1) 44.5 (9.7) 46.1 (9.6) 47.9 (9.3) 49.6 (8.8) 49.6 (8.5) 49.5 (8.5) <0.001 
Bodily Pain† 48.7 (10.1) 46.1 (10.9) 46.5 (11.6) 48.5 (10.1) 49.5 (9.7) 49.0 (9.7) 49.8 (9.3) <0.001 
General Health† 50.1 (9.7) 44.8 (10.8) 47.1 (10.2) 49.5 (9.4) 51.2 (9.3) 52.1 (8.9) 52.2 (8.8) <0.001 
Mental Component † 55.5 (7.5) 54.6 (9.0) 55.1 (8.4) 55.2 (7.9) 55.5 (7.0) 56.0 (6.8) 56.4 (6.4) 0.002 
Mental Health†  54.9 (7.9) 53.3 (9.1) 54.0 (8.8) 54.7 (8.0) 55.1 (7.6) 55.7 (7.1) 56.2 (7.0) <0.001 
Role Emotional† 51.9 (7.5) 49.7 (9.4) 51.1 (7.9) 51.1 (8.2) 52.5 (6.9) 52.7 (6.4) 52.6 (6.8) <0.001 
Social Functioning† 52.7 (7.9) 51.0 (9.5) 51.6 (8.7) 52.5 (8.0) 53.1 (7.8) 53.4 (7.0) 53.4 (6.9) <0.001 
Vitality† 53.1 (9.1) 50.4 (9.6) 50.9 (9.3) 52.8 (9.1) 53.8 (8.9) 53.9 (8.7) 54.3 (8.6) <0.001 
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Table S3. Partially adjusted† difference in quality of life (QOL) scores according to ankle brachial index (ABI) categories (Model 1)   
QOL Domains 
ABI categories (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
Coefficient‡ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Physical Components -5.28 (-8.32 to -2.24)* -3.72 (-5.03 to -2.41)* -1.29 (-1.82 to -0.75)* 0 -0.39 (-1.98 to 1.20) -0.72 (-1.90 to 0.47) 
Physical Functioning -5.41 (-8.11 to -2.71)* -3.17 (-5.02 to -1.33)* -1.33 (-2.12 to -0.55)* 0 -0.03 (-2.05 to 2.00) -1.01 (-2.78 to 0.76) 
Role Physical -4.33 (-7.14 to -1.52)* -3.03 (-4.01 to -2.04)* -1.41 (-2.34 to -0.48)* 0 -0.32 (-1.21 to 0.58) -0.44 (-2.02 to 1.14) 
Bodily Pain -3.21 (-5.24 to -1.19)* -2.60 (-4.34 to -0.85)* -0.61 (-0.94 to -0.29)* 0 -0.91 (-2.59 to 0.77) -0.47 (-2.29 to 1.34) 
General Health -4.12 (-5.97 to -2.26)* -2.71 (-4.26 to -1.17)* -0.69 (-2.05 to 0.68) 0 0.14 (-1.26 to 1.54) 0.16 (-0.35 to 0.68) 
Mental Components -0.34 (-2.25 to 1.57) -0.01 (-1.04 to 1.03) 0.00 (-0.60 to 0.61) 0 0.11 (-0.54 to 0.76) 0.37 (-0.51 to 1.26) 
Mental Health -1.24 (-2.84 to 0.36) -0.42 (-0.77 to -0.06)* 0.11 (-0.73 to 0.96) 0 0.11 (-1.00 to 1.21) 0.39 (-0.82 to 1.60) 
Role Emotional -2.00 (-3.60 to -0.39)* -0.83 (-2.10 to 0.43) -0.93 (-1.70 to -0.16)* 0 -0.09 (-0.93 to 0.75) -0.32 (-1.44 to 0.79) 
Social Functioning -1.28 (-2.88 to 0.32) -1.01 (-2.61 to 0.59) -0.19 (-0.51 to 0.13) 0 0.05 (-1.23 to 1.34) -0.07 (-1.52 to 1.39) 
Vitality -2.89 (-4.54 to -1.25)* -2.41 (-3.11 to -1.71)* -0.62 (-1.25 to 0.02) 0 -0.20 (-0.90 to 0.50) 0.05 -0.83 to 0.94) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status. 
‡ Linear regression coefficient: It represents the difference in QOL score between a given ABI category to the reference category (1.10-1.19). 
 5 
Table S4. Partially adjusted† difference in quality of life (QOL) scores according to ankle brachial index (ABI) categories (Model 2)    
QOL Domains 
ABI categories (n) 
<0.90 (402) 0.90-0.99 (426) 1.00-1.09 (1,234) 1.10-1.19 (1,900) 1.20-1.29 (694) ≥1.30 (459) 
Coefficient‡ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Physical Components -4.40 (-6.88 to -1.92)* -2.82 (-4.28 to -1.36)* -0.84 (-1.46 to -0.23)* 0 -0.38 (-1.62 to 0.86) -0.07 (-0.80 to 0.66) 
Physical Functioning -4.62 (-6.83 to -2.42)* -2.32 (-4.19 to -0.46)* -0.92 (-1.71 to -0.14)* 0 -0.03 (-1.59 to 1.54) -0.37 (-1.71 to 0.96) 
Role Physical -3.65 (-6.01 to -1.28)* -2.34 (-3.76 to -0.91)* -1.08 (-2.30 to 0.14) 0 -0.31 (-1.28 to 0.65) 0.03 (-1.36 to 1.42) 
Bodily Pain -2.59 (-4.23 to -0.94)* -1.91 (-3.69 to -0.14)* -0.27 (-0.92 to 0.37) 0 -0.91 (-2.36 to 0.54) 0.01 (-1.40 to 1.42) 
General Health -3.27 (-4.76 to -1.79)* -2.06 (-3.54 to -0.57)* -0.35 (-1.59 to 0.89) 0 0.16 (-1.07 to 1.39) 0.56 (-0.25 to 1.38) 
Mental Components -0.17 (-2.32 to 1.98) 0.09 (-1.07 to 1.24) 0.03 (-0.57 to 0.63) 0 0.11 (-0.62 to 0.84) 0.38 (-0.46 to 1.23) 
Mental Health -0.92 (-2.75 to 0.91) -0.15 (-0.72 to 0.42) 0.22 (-0.62 to 1.06) 0 0.09 (-1.06 to 1.25) 0.49 (-0.63 to 1.60) 
Role Emotional -1.73 (-3.33 to -0.14)* -0.61 (-1.84 to 0.63) -0.82 (-1.59 to -0.05)* 0 -0.08 (-0.85 to 0.69) -0.15 (-1.04 to 0.75) 
Social Functioning -1.03 (-2.55 to 0.49) -0.76 (-2.40 to 0.88) -0.08 (-0.48 to 0.33) 0 0.06 (-1.20 to 1.31) 0.12 (-1.27 to 1.50) 
Vitality -2.17 (-3.41 to -0.93)* -1.75 (-2.25 to -1.25)* -0.32 (-0.73 to 0.10) 0 -0.21 (-0.77 to 0.36) 0.46 (-0.12 to 1.05) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, hypertension, 
history of coronary heart disease, history of heart failure and history of stroke  
‡ Linear regression coefficient: It represents the difference in QOL score between a given ABI category to the reference category (1.10-1.19). 
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Table S5. Partially adjusted† odds-ratio of other quality of life (QOL) aspects according to ankle brachial index (ABI) categories 
(Model 1) 
Other QOL 
Aspects 
ABI categories (n) 
<0.90  
(402) 
0.90-0.99  
(426) 
1.00-1.09  
(1,234) 
1.10-1.19  
(1,900) 
1.20-1.29  
(694) 
≥1.30  
(459) 
OR‡ (95% CI) OR (95% CI) OR (95% CI) Ref OR (95% CI) OR (95% CI) 
Physical Activity        
“Low” leisure time exercise 1.51 (1.20 to 1.90)* 1.54 (1.06 to 2.23)* 1.28 (1.13 to 1.45)* 1 1.01 (0.80 to 1.28) 1.01 (0.71 to 1.42) 
“Low” leisure time activity 1.74 (1.51 to 2.01)* 1.58 (1.36 to 1.83)* 1.26 (1.11 to 1.42)* 1 0.74 (0.59 to 0.92)* 0.90 (0.67 to 1.20) 
“Low” leisure time walk 1.62 (1.42 to 1.85)* 1.56 (1.17 to 2.09)* 1.31 (1.16 to 1.49)* 1 0.93 (0.76 to 1.13) 0.99 (0.84 to 1.16) 
Mental Health       
Significant depressive symptoms 1.97 (1.14 to 3.41)* 1.46 (1.00 to 2.14)* 1.32 (1.10 to 1.59)* 1 0.78 (0.48 to 1.27) 1.02 (0.65 to 1.61) 
Feel Hopeless 1.33 (1.10 to 1.61)* 1.37 (1.26 to 1.50)* 1.39 (1.03 to 1.88)* 1 0.91 (0.64 to 1.30) 1.02 (0.56 to 1.84) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status. 
‡ Logistic regression models were applied to assess the 5 binary other QOL aspects.  
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Table S6. Partially adjusted† odds-ratio of other quality of life (QOL) aspects according to ankle brachial index (ABI) categories 
(Model 2) 
Other QOL 
Aspects 
ABI categories (n) 
<0.90  
(402) 
0.90-0.99  
(426) 
1.00-1.09  
(1,234) 
1.10-1.19 
(1,900) 
1.20-1.29  
(694) 
≥1.30  
(459) 
OR‡ (95% CI) OR (95% CI) OR (95% CI) Ref OR (95% CI) OR (95% CI) 
Physical Activity        
“Low” leisure time exercise 1.38 (1.12 to 1.71)* 1.41 (1.00 to 1.99) 1.22 (1.10 to 1.36)* 1 1.01 (0.79 to 1.29) 0.95 (0.68 to 1.33) 
“Low” leisure time activity 1.51 (1.38 to 1.66)* 1.36 (1.18 to 1.57)* 1.17 (1.09 to 1.27)* 1 0.73 (0.60 to 0.90)* 0.78 (0.58 to 1.04) 
“Low” leisure time walk 1.50 (1.33 to 1.69)* 1.44 (1.14 to 1.82)* 1.26 (1.13 to 1.42)* 1 0.93 (0.77 to 1.12) 0.92 (0.79 to 1.07) 
Mental Health       
Significant depressive symptoms 1.76 (0.99 to 3.13) 1.32 (0.85 to 2.03) 1.27 (1.04 to 1.56)* 1 0.78 (0.47 to 1.28) 0.92 (0.60 to 1.42) 
Feel Hopeless 1.21 (1.01 to 1.45)* 1.27 (1.12 to 1.44)* 1.35 (0.99 to 1.83) 1 0.91 (0.63 to 1.30) 0.95 (0.53 to 1.71) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, hypertension, 
history of coronary heart disease, history of heart failure and history of stroke. 
‡ Logistic regression models were applied to assess the 5 binary other QOL aspects. 
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Table S7. Adjusted† difference in Physical Component Summary scores across ankle brachial index (ABI) categories in different 
subgroups 
Subgroups 
ABI categories (n) 
P value for 
interaction 
<0.90 0.90-0.99 1.00-1.09 1.10-1.19 1.20-1.29 ≥1.30 
 
Coefficient‡ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Sex        
Males -3.84 (-8.25 to 0.57) -1.72 (-3.68 to 0.24) -0.46 (-1.90 to 0.98) 0 0.57 (-0.30 to 1.45) 0.28 (-1.01 to 1.56) 
0.014* 
Females -2.56 (-5.39 to 0.27) -2.44 (-4.41 to -0.48)* -0.74 (-2.20 to 0.73) 0 -1.88 (-4.33 to 0.58) -0.45 (-2.73 to 1.83) 
Ethnicity        
Caucasians -3.68 (-7.13 to -0.23) * -2.00 (-4.53 to 0.53) -0.48 (-1.40 to 0.45) 0 -0.37 (-0.87 to 0.12) 0.05 (-0.90 to 1.00) 
0.051 
African Americans -3.05 (-3.78 to -2.31) * -2.73 (-3.79 to -1.68)* -0.88 (-1.49 to -0.27)* 0 -2.47 (-6.31 to 1.36) -1.54 (-3.01 to -0.07)* 
CVD History        
No CVD history -4.54 (-7.70 to -1.38) * -2.56 (-5.23 to 0.10) -0.67 (-1.73 to 0.39) 0 -0.96 (-2.29 to 0.38) -0.42 (-2.20 to 1.36) 
0.001* 
CVD history -1.10 (-2.82 to 0.62) -1.01 (-3.62 to 1.60) -0.22 (-1.15 to 0.71) 0 1.58 (-0.64 to 3.80) 1.20 (-2.02 to 4.41) 
Diabetes        
No Diabetes  -3.60 (-7.10 to -0.09)* -2.56 (-4.81 to -0.31)* -0.95 (-2.64 to 0.74) 0 -1.05 (-2.43 to 0.33) -0.39 (-1.76 to 0.98) 
0.388 
Diabetes  -2.37 (-3.20 to -1.53)* -1.32 (-5.83 to 3.18) 0.19 (-1.25 to 1.64) 0 0.63 (-0.88 to 2.14) 0.71 (-1.52 to 2.94) 
Reduced Kidney 
Function  
       
Not Reduced  -3.33 (-5.59 to -1.06)* -2.78 (-4.79 to -0.77)* -1.26 (-2.46 to -0.07)* 0 -1.00 (-2.16 to 0.17) -0.04 (-1.64 to 1.56) 
0.096 
Reduced   -2.86 (-5.40 to -0.31)* -0.87 (-2.94 to 1.20) 1.14 (-0.14 to 2.43) 0 0.84 (-2.85 to 4.52) -0.26 (-1.66 to 1.13) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, hypertension, 
cardiovascular disease (CVD) history, lung disease and reduced kidney function (excluding corresponding covariate indicating each subgroup). 
‡ Linear regression coefficient: It represents the difference in Physical Component Summary score between ABI category <1.00 and the reference category 
(≥1.00). 
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Table S8. Adjusted† odds-ratio of other physical activity aspects for lower ankle brachial index (ABI) (<1.00) in different subgroups. 
Subgroups 
Physical Activity Aspects 
“Low” leisure time exercise “Low” leisure time activity “Low” leisure time walk 
Case/N‡ OR§ (95% CI) Case/N OR (95% CI) Case/N OR (95% CI) 
Sex       
Males 162/316  1.30 (0.91 to 1.87) 56/316  1.10 (0.81 to 1.48) 104/316  1.34 (1.05 to 1.71)* 
Females 316/512  1.25 (1.04 to 1.50)* 148/512  1.41 (1.18 to 1.69)* 216/512  1.30 (1.18 to 1.43)* 
P value for interaction 0.854 0.661 0.629 
Ethnicity       
Caucasians 314/531  1.38 (1.01 to 1.88)* 122/531  1.29 (1.14 to 1.47)* 206/531  1.38 (1.14 to 1.66)* 
African Americans 164/297  1.10 (0.98 to 1.23) 82/297  1.27 (1.24 to 1.30)* 114/297  1.18 (1.07 to 1.30)* 
P value for interaction 0.150 0.686 0.278 
CVD History       
No CVD history 329/565  1.31 (1.01 to 1.70)* 149/565  1.50 (1.34 to 1.69)* 226/565  1.41 (1.24 to 1.61)* 
CVD history 149/263  1.17 (0.91 to 1.51) 55/263  0.96 (0.69 to 1.32) 94/263  1.08 (0.84 to 1.39) 
P value for interaction 0.185 0.007* < 0.001* 
Diabetes       
No Diabetes  276/513  1.14 (0.83 to 1.56) 111/513  1.47 (1.04 to 2.07)* 192/513  1.40 (1.04 to 1.88)* 
Diabetes  202/315  1.57 (1.21 to 2.03)* 93/315  1.08 (0.79 to 1.48) 128/315  1.18 (0.88 to 1.57) 
P value for interaction 0.315 0.262 0.352 
Reduced Kidney Function        
Not Reduced  283/492  1.35 (1.06 to 1.71)* 117/492  1.42 (1.24 to 1.62)* 176/492  1.35 (1.17 to 1.56)* 
Reduced   195/336  1.15 (0.86 to 1.53) 87/336  1.15 (0.88 to 1.50) 144/336  1.26 (1.04 to 1.53) 
P value for interaction 0.383 0.069 0.662 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, 
hypertension, cardiovascular disease (CVD) history, lung disease and reduced kidney function (excluding corresponding covariate indicating each 
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subgroup). 
‡ Number of individuals having outcome with ABI < 1.00 for each subgroup/ Total number of individuals with ABI < 1.00 for each subgroup. 
§ Logistic regressions were applied to assess the odds ratio for 3 binary physical activity aspects between ABI <1.00 and the reference category (≥1.00).  
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Table S9. Adjusted† difference in Mental Component Summary scores across ankle brachial index (ABI) categories in different 
subgroups 
Subgroups 
ABI categories (n) 
P value for 
interaction 
<0.90 0.90-0.99 1.00-1.09 1.10-1.19 1.20-1.29 ≥1.30 
Coefficient‡ (95% CI) Coefficient (95% CI) Coefficient (95% CI) Ref Coefficient (95% CI) Coefficient (95% CI) 
Sex        
Males 0.27 (-2.23 to 2.78) -0.71 (-2.16 to 0.75) 0.62 (-0.20 to 1.44) 0 0.19 (-1.01 to 1.40) 0.19 (-0.74 to 1.12) 
0.280 
Females -0.36 (-2.21 to 1.48) 0.47 (-1.46 to 2.40) -0.20 (-0.88 to 0.49) 0 0.06 (-1.90 to 2.02) 0.95 (-0.74 to 2.64) 
Ethnicity        
Caucasians -0.39 (-2.85 to 2.07) 0.09 (-1.37 to 1.55) 0.20 (-0.41 to 0.81) 0 0.26 (-0.27 to 0.80) 0.58 (-0.15 to 1.31) 
0.152 
African Americans 0.24 (-1.55 to 2.04) 0.14 (-0.55 to 0.83) -0.41 (-2.08 to 1.25) 0 -0.73 (-1.89 to 0.43) -0.50 (-1.00 to -0.01)* 
CVD History        
No CVD history -0.39 (-2.87 to 2.10) 0.39 (-0.84 to 1.61) 0.04 (-0.63 to 0.71) 0 0.24 (-0.42 to 0.91) 0.35 (-0.58 to 1.28) 
0.011* 
CVD history 0.29 (-1.57 to 2.16) -0.53 (-1.68 to 0.63) 0.20 (-1.39 to 1.79) 0 -0.81 (-2.39 to 0.77) 0.31 (-0.14 to 0.76) 
Diabetes        
No Diabetes  -0.37 (-1.73 to 1.00) 0.09 (-1.25 to 1.44) -0.05 (-1.21 to 1.11) 0 0.30 (-0.08 to 0.67) 0.47 (-1.14 to 2.09) 
0.976 
Diabetes  0.36 (-2.86 to 3.57) 0.61 (-2.23 to 3.45) 0.33 (-1.87 to 2.53) 0 -0.27 (-2.17 to 1.63) 0.31 (-1.13 to 1.76) 
Reduced Kidney 
Function§  
       
Not Reduced  0.31 (-2.78 to 3.41) 0.59 (0.09 to 1.08)* 0.44 (-0.22 to 1.10) 0 0.22 (-0.19 to 0.64) 0.37 (-1.09 to 1.83) 
0.031* 
Reduced   -0.96 (-3.85 to 1.93) -0.85 (-2.84 to 1.14) -0.99 (-2.60 to 0.61) 0 -0.35 (-3.59 to 2.89) 0.19 (-0.84 to 1.21) 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, hypertension, 
cardiovascular disease (CVD) history, lung disease and reduced kidney function (excluding corresponding covariate indicating each subgroup). 
‡ Linear regression coefficient: It represents the difference in Mental Component Summary score between ABI category <1.00 and the reference category 
(≥1.00). 
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Table S10. Adjusted† odds-ratio of other mental health aspects for lower ankle brachial index (ABI) (<1.00) in different subgroups. 
Subgroups 
 Mental Health Aspects 
Significant depressive symptoms Hopeless feeling 
Case/N‡ OR§ (95% CI) Case/N OR (95% CI) 
Sex     
Males 24/316  1.22 (0.62 to 2.39) 37/316  1.09 (0.84 to 1.42) 
Females 57/512  1.29 (0.68 to 2.43) 74/512  1.04 (0.78 to 1.40) 
P value for interaction 0.809 0.289 
Ethnicity     
Caucasians 51/531  1.65 (1.05 to 2.59)* 70/531  1.23 (1.10 to 1.36)* 
African Americans 30/297  0.84 (0.74 to 0.96)* 41/297  0.83 (0.78 to 0.88)* 
P value for interaction 0.001* < 0.001* 
CVD History     
No CVD history 52/565  1.20 (0.69 to 2.09) 77/565  1.06 (0.70 to 1.59) 
CVD history 29/263  1.50 (0.88 to 2.58) 34/263  1.11 (0.79 to 1.57) 
P value for interaction 0.036* 0.936 
Diabetes     
No Diabetes  40/513  1.23 (0.51 to 2.94) 64/513  1.15 (0.89 to 1.50) 
Diabetes  41/315  1.28 (0.81 to 2.02) 47/315  0.91 (0.61 to 1.37) 
P value for interaction 0.975 0.070 
Reduced Kidney Function      
Not Reduced  41/492  1.11 (0.70 to 1.75) 61/492  1.05 (0.73 to 1.51) 
Reduced   40/336  1.63 (0.73 to 3.62) 50/336  1.07 (0.81 to 1.40) 
P value for interaction 0.271 0.809 
* Indicates significant results. 
† Adjusted for age, sex, ethnicity, education level, economic status, current smoking/drinking status, body mass index, total cholesterol, diabetes, 
hypertension, cardiovascular disease (CVD) history, lung disease and reduced kidney function (excluding corresponding covariate indicating each 
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subgroup). 
‡ Number of individuals having outcome with ABI < 1.00 for each subgroup / Total number of individuals with ABI < 1.00 for each subgroup. 
§ Logistic regressions were applied to assess the odds ratio for 2 binary mental health aspects between ABI <1.00 and the reference category (≥1.00). 
